Kymera Therapeutics Inc (KYMR) stock is down -43.49% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives KYMR stock a score of 35 out of a possible 100.
That rank is influenced by a short-term technical score of 2. KYMR's rank also includes a long-term technical score of 13. KYMR has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on KYMR!